IndiaTickerLatest filing: Sudeep Pharma Ltd - 544619 - Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations, 2011
ObservedCompany dossier
Sudeep Pharma
NSE:SUDEEPPHRM · ISIN INE0QPI01025
- Close
- ₹879.15 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Sudeep Pharma
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest ownership: promoter group 76.15% and public 23.85% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Sudeep Pharma Ltd - 544619 - Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations, 2011
BSE · exchange filing
Observed
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Sudeep Pharma Limited
NSE · conference call
Observed
Source filing Sudeep Pharma Ltd - 544619 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
BSE · conference call
Observed
Source filing Sudeep Pharma Ltd - 544619 - Board Meeting Intimation for Adoption Of Unaudited Financials (Standalone & Consolidated) For The Quarter Ended 30Th June 2026
BSE · exchange filing
Reported financials
Full financials →Awaiting structured filing
No reconciled records in this module yet
Structured financial facts have not been reconciled.
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 76.15%
- Public
- 23.85%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL